Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Fehmann

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Fortschritte Der Medizin. Originalien|February 11, 2005
[Treatment of type 2 diabetes mellitus with the alpha-glucosidase inhibitor Miglitol in the doctor's office]H C Fehmann
Deutsche Medizinische Wochenschrift (1946)|June 13, 2003
[A 47-year-old man with "pure autonomic failure" and pernicious anemia]H C Fehmann
Fortschritte Der Medizin. Originalien|February 12, 2005
[The alpha-glucosidase inhibitor miglitol for the treatment of type 2 diabetes mellitus in the doctor's office]H C Fehmann
Zeitschrift Fur Gastroenterologie|October 17, 2003
[The functional relation between the gut and the liver: the newly discovered hormone relm-beta affects the action of insulin]H C Fehmann
MMW Fortschritte Der Medizin|June 29, 2000
[Alpha-glucosidase inhibitor for type 2 diabetic patients. Clinical study with miglitol]H C Fehmann
MMW Fortschritte Der Medizin|August 9, 2001
[Alpha-glucosidase inhibitor in type 2 diabetic patients. Metabolism and body weight are favorably modified]H C Fehmann
Deutsche Medizinische Wochenschrift (1946)|May 22, 2001
[Nutrition-dependent Cushing syndrome with lengthy anamnesis and moderate clinical aspects]H C Fehmann
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 28, 2003
Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controlsH-C Fehmann, J Heyn
Peptides|January 1, 1995
Characterization of GIP(1-30) and GIP(1-42) as stimulators of proinsulin gene transcriptionH C Fehmann, B Göke
Trends in Endocrinology and Metabolism: TEM|October 1, 1993
International symposium on glucagonlike peptide I, Copenhagen, Denmark, 17-19 May 1993H C Fehmann, B Goke
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Fortschritte Der Medizin. Originalien|February 11, 2005
[Treatment of type 2 diabetes mellitus with the alpha-glucosidase inhibitor Miglitol in the doctor's office]H C Fehmann
Deutsche Medizinische Wochenschrift (1946)|June 13, 2003
[A 47-year-old man with "pure autonomic failure" and pernicious anemia]H C Fehmann
Fortschritte Der Medizin. Originalien|February 12, 2005
[The alpha-glucosidase inhibitor miglitol for the treatment of type 2 diabetes mellitus in the doctor's office]H C Fehmann
Zeitschrift Fur Gastroenterologie|October 17, 2003
[The functional relation between the gut and the liver: the newly discovered hormone relm-beta affects the action of insulin]H C Fehmann
MMW Fortschritte Der Medizin|June 29, 2000
[Alpha-glucosidase inhibitor for type 2 diabetic patients. Clinical study with miglitol]H C Fehmann
MMW Fortschritte Der Medizin|August 9, 2001
[Alpha-glucosidase inhibitor in type 2 diabetic patients. Metabolism and body weight are favorably modified]H C Fehmann
Deutsche Medizinische Wochenschrift (1946)|May 22, 2001
[Nutrition-dependent Cushing syndrome with lengthy anamnesis and moderate clinical aspects]H C Fehmann
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 28, 2003
Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controlsH-C Fehmann, J Heyn
Peptides|January 1, 1995
Characterization of GIP(1-30) and GIP(1-42) as stimulators of proinsulin gene transcriptionH C Fehmann, B Göke
Trends in Endocrinology and Metabolism: TEM|October 1, 1993
International symposium on glucagonlike peptide I, Copenhagen, Denmark, 17-19 May 1993H C Fehmann, B Goke
Pageof 10